Trial intelligence / Profile preview

Lopinavir/Ritonavir vs Efavirenz in HIV Naive Patients

NCT01049685Phase 4Unknown

Sponsor
Hospital das Clínicas da Faculdade de Medicina de Botucatu
Start
Aug 2006
Primary completion
Dec 2009
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of lopinavir, ritonavir, efavirenz in human immunodeficiency virus infection (HIV), sponsored by Hospital das Clínicas da Faculdade de Medicina de Botucatu. Status: unknown.

02

Drugs

lopinavirritonavirefavirenz
03

Conditions

human immunodeficiency virus infection (HIV)

Beyond the preview

Go deeper on NCT01049685.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01049685.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call